Delivery Order SPE2DB22D2218-SPE2DB24FR2DT
Award Date 3/11/24
Potential Completion Date 3/12/24
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,244.58 firm fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Contrave ER 8-90 mg tablets in quantities of 120. The contract has a firm fixed price of $11,258.41 and a completion date of February 21, 2024. This contract is a delivery order, not associated with a larger vehicle. There was no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,557.67 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $18,709.96 with a firm fixed price, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,770.94 firm fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,892.61, is a delivery order for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,953.95 Firm Fixed Price Delivery Order contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $3,875.67 firm fixed-price delivery order has a completion date of May 13, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,797.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of May 31, 2024. This contract appears to be a delivery order and is not associated with a set-aside designation, indicating open competition. AmerisourceBergen also holds a...